← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2005-05-03

Drug application

FDA Application #

ANDA065183

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

POWDER

Route

TOPICAL

Marketing status

Prescription

Sponsor

UPSHER SMITH LABS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2005-05-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown